Yebin Lu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 10
- Circular RNAs in diseases 5
- Extracellular vesicles in disease 2
-
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 10
- Co-authors
- Ling Tang (3 shared papers)Zhenglin Ou (4 shared papers)Bo Yang (2 shared papers)Yu Liu (2 shared papers)Shuai Liang (5 shared papers)Wei Wei (1 shared paper)Weijia Sun (5 shared papers)Xiaohui Duan (4 shared papers)
In The Last Decade
Yebin Lu
21 papers receiving 874 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 637
- Molecular Biology 619
- Immunology 162
- Oncology 192
- Epidemiology 75
Countries citing papers authored by Yebin Lu
This map shows the geographic impact of Yebin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yebin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yebin Lu more than expected).
Fields of papers citing papers by Yebin Lu
This network shows the impact of papers produced by Yebin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yebin Lu. The network helps show where Yebin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yebin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 168 | |
| 2 | 2019 | 140 | |
| 3 | 2010 | 84 | |
| 4 | 2018 | 49 | |
| 5 | 2017 | 44 | |
| 6 | 2015 | 43 | |
| 7 | 2015 | 43 | |
| 8 | 2017 | 42 | |
| 9 | 2017 | 42 | |
| 10 | 2010 | 41 | |
| 11 | 2017 | 38 | |
| 12 | 2019 | 35 | |
| 13 | 2019 | 30 | |
| 14 | 2017 | 28 | |
| 15 | 2016 | 20 | |
| 16 | 2023 | 10 | |
| 17 | 2023 | 7 | |
| 18 | 2018 | 7 | |
| 19 | 2023 | 5 | |
| 20 | 2014 | 3 |
About Yebin Lu
Yebin Lu is a scholar working on Molecular Biology, Cancer Research, Immunology, Surgery and Oncology, having authored 23 papers that have together received 881 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (5 papers), Immune Cell Function and Interaction (5 papers), Immune cells in cancer (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (637 citations), Molecular Biology (619 citations), Immunology (162 citations), Oncology (192 citations) and Epidemiology (75 citations). Yebin Lu has collaborated with scholars based in China and Germany. Frequent co-authors include Ling Tang, Zhenglin Ou, Bo Yang, Yu Liu, Shuai Liang, Wei Wei, Weijia Sun, Xiaohui Duan, Qi Zhang and Xuejun Gong. Their work appears in journals such as Oncotarget, Journal of Cellular Biochemistry, RNA Biology, Frontiers in Immunology and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.